AORT (Artivion) Shareholder Yield % : 9.36% (As of Mar. 2026)


AORT Artivion Inc AORT
81 GF Score
Price $23.46
GF Value $28.39
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Artivion Shareholder Yield %?

Artivion AORT +4.41% 81 Shareholder Yield % is 9.36% as of Mar. 2026. GuruFocus rates AORT with a GF Score™ of 81/100 and a GF Value™ of $28.39 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Artivion ranks better than 91.92% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Artivion's Shareholder Yield % was 9.36%.


Artivion  (NYSE:AORT) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Artivion Shareholder Yield % Related Terms


Artivion Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Artivion's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artivion Shareholder Yield % Chart

Artivion Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.64 0.42 0.20 -0.49 3.49

Artivion Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 1.52 2.44 3.49 5.75

AORT vs LMRI, AVNS, TNDM: Shareholder Yield % Comparison

For the Medical Devices subindustry, Artivion's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artivion Shareholder Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Artivion's Shareholder Yield % falls into.


AORT
81GF Score
Artivion Inc AORT
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artivion Shareholder Yield % Calculation

Artivion's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0.00 %+5.75 %
=5.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 9.36% mean?
Artivion (AORT) has a Shareholder Yield % of 9.36% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Artivion and its competitors. According to the industry distribution chart, Artivion ranks #66 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 8.1%.
Is Artivion's Shareholder Yield % too high?
Artivion's current Shareholder Yield % is 9.36%. The Medical Devices & Instruments industry median Shareholder Yield % is 0.14. Artivion's value of 9.36% is 6585.7% above this industry median. Based on the distribution chart, Artivion ranks #66 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Artivion has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Artivion's Shareholder Yield % compare to LMRI and AVNS?
According to the Medical Devices & Instruments industry distribution chart, Artivion ranks #66 out of 817 companies for Shareholder Yield %. This places Artivion in the top 8% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 0.14. Artivion's value of 9.36% is 6585.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Devices & Instruments company?
The median Shareholder Yield % among Medical Devices & Instruments companies is 0.14, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artivion's current Shareholder Yield % of 9.36% is 6585.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Artivion and its competitors. For the Medical Devices & Instruments industry, the median Shareholder Yield % is 0.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artivion's current Shareholder Yield % is 9.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artivion stock overvalued right now?
Based on GuruFocus' analysis, Artivion (AORT) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.39, compared to a current price of $23.46 — trading 17.4% below its estimated fair value. The current Shareholder Yield % is 9.36% and 6585.7% above the Medical Devices & Instruments industry median of 0.14. Artivion's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Artivion (AORT), the current Shareholder Yield % is 9.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Artivion (AORT) Overvalued in 2026?

Based on GuruFocus' analysis, Artivion stock appears to be undervalued. The current stock price of $23.46 is trading 17.4% below its estimated GF Value™ of $28.39. GuruFocus considers Artivion to be Modestly Undervalued.

Key valuation signals for AORT:

  • Shareholder Yield %: 9.36%
  • GF Value™: $28.39 vs. price of $23.46 (17.4% below fair value)
  • GF Score™: 81/100 with 5 warning signs
  • Industry Position: 6585.7% above the Medical Devices & Instruments median (#66 of 817)

No single metric tells the full story. See the AORT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Artivion Business Description

Other Exchanges CYL:Germany
Address 1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
81GF Score

Get the complete analysis for AORT

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.46
Price
$28.39
GF Value